Correlation Between Bausch Health and Biohaven Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Bausch Health and Biohaven Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bausch Health and Biohaven Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bausch Health Companies and Biohaven Pharmaceutical Holding, you can compare the effects of market volatilities on Bausch Health and Biohaven Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bausch Health with a short position of Biohaven Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bausch Health and Biohaven Pharmaceutical.
Diversification Opportunities for Bausch Health and Biohaven Pharmaceutical
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Bausch and Biohaven is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Bausch Health Companies and Biohaven Pharmaceutical Holdin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biohaven Pharmaceutical and Bausch Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bausch Health Companies are associated (or correlated) with Biohaven Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biohaven Pharmaceutical has no effect on the direction of Bausch Health i.e., Bausch Health and Biohaven Pharmaceutical go up and down completely randomly.
Pair Corralation between Bausch Health and Biohaven Pharmaceutical
Considering the 90-day investment horizon Bausch Health Companies is expected to generate 0.9 times more return on investment than Biohaven Pharmaceutical. However, Bausch Health Companies is 1.11 times less risky than Biohaven Pharmaceutical. It trades about 0.17 of its potential returns per unit of risk. Biohaven Pharmaceutical Holding is currently generating about 0.1 per unit of risk. If you would invest 607.00 in Bausch Health Companies on September 3, 2024 and sell it today you would earn a total of 230.00 from holding Bausch Health Companies or generate 37.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Bausch Health Companies vs. Biohaven Pharmaceutical Holdin
Performance |
Timeline |
Bausch Health Companies |
Biohaven Pharmaceutical |
Bausch Health and Biohaven Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bausch Health and Biohaven Pharmaceutical
The main advantage of trading using opposite Bausch Health and Biohaven Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bausch Health position performs unexpectedly, Biohaven Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will offset losses from the drop in Biohaven Pharmaceutical's long position.Bausch Health vs. Viatris | Bausch Health vs. Catalent | Bausch Health vs. Tilray Inc | Bausch Health vs. Zoetis Inc |
Biohaven Pharmaceutical vs. Immunome | Biohaven Pharmaceutical vs. Inhibrx | Biohaven Pharmaceutical vs. Day One Biopharmaceuticals | Biohaven Pharmaceutical vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |